ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 1290

$432K Total Retail Price of All Prescriptions

Rank: 237 out of 1290

527 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 6,026 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 276 214 1 2
AMLODIPINE BESYLATE 271 223 2 3
PRAVASTATIN SODIUM 271 199 2 42
METFORMIN HCL 243 185 4 10
SIMVASTATIN 223 168 5 1
LEVOTHYROXINE SODIUM 194 149 6 4
LISINOPRIL 193 158 7 5
FLUTICASONE PROPIONATE 179 142 8 26
ATORVASTATIN CALCIUM 177 136 9 23
ENALAPRIL MALEATE 170 116 10 62
HYDROCHLOROTHIAZIDE 153 122 11 20
FUROSEMIDE 144 122 12 9
ALENDRONATE SODIUM 137 118 13 39
METOPROLOL SUCCINATE 123 93 14 14
LOSARTAN POTASSIUM 121 92 15 19
PROAIR HFA 121 77 15 73
CARVEDILOL 116 102 17 12
GLIPIZIDE 115 99 18 81
GLIPIZIDE ER 112 99 19 206
POTASSIUM CHLORIDE 107 97 20 35
MELOXICAM 104 71 21 31
TRAMADOL HCL 97 48 22 25
AZITHROMYCIN 95 77 23 61
CLOPIDOGREL 94 62 24 24
IBUPROFEN 87 51 25 74
CRESTOR 86 66 26 17
METFORMIN HCL ER 82 69 27 135
GABAPENTIN 82 46 27 8
AMOXICILLIN 81 59 29 227
LOSARTAN-HYDROCHLOROTHIAZIDE 77 61 30 106
ZOLPIDEM TARTRATE 75 21 31 15
TERAZOSIN HCL 74 55 32 157
NOVOLOG MIX 70-30 72 56 33 272
PREDNISONE 68 39 34 21
METOPROLOL TARTRATE 66 59 35 7
INSULIN SYRINGE 62 42 36 76
VENTOLIN HFA 60 54 37 123
PLAVIX 54 36 38 32
ALPRAZOLAM 54 46 38 47
CLONIDINE HCL 54 26 38 66
TAMSULOSIN HCL 52 46 41 11
GEMFIBROZIL 52 32 41 210
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 37 41 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.